HEART REVIEW

Non-cardiac comorbidities in chronic heart failure

Chim C Lang¹, Donna M Mancini²

¹ Department of Cardiology, Ninewells Hospital and Medical School, Dundee, UK
² Department of Medicine, Columbia University College of Physicians and Surgeons, New York, USA

Correspondence to:
Professor C C Lang
Department of Cardiology, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK;c.c.lang{at}dundee.ac.uk

Non-cardiac comorbidity complicates heart failure care and is prevalent in one form or another for the majority of elderly patients with heart failure. This wide range of comorbidities, which includes respiratory comorbidities, renal dysfunction, anaemia, arthritis, cognitive dysfunction and depression, contributes to the progression of the disease and may alter the response to treatment. Polypharmacy is inevitable in these patients. Cardiologists and other physicians caring for patients with chronic heart failure (CHF) need to be vigilant to comorbid conditions that may complicate the care of these patients. Future trials should focus on optimal strategies for the comprehensive management of the elderly patients with CHF with multiple comorbidities rather than the isolated effects of single drugs in younger patients with few or no comorbidities.

Abbreviations: BNP, brain natriuretic peptide; CHF, chronic heart failure; COPD, chronic obstructive pulmonary disease; CPAP, continuous positive airway pressure; CSA, central sleep apnoea; HF, heart failure; NYHA, New York Heart Association; OSA, obstructive sleep apnoea; rHuEPO, recombinant human erythropoietin; SDB, sleep-disordered breathing; TNF, tumour necrosis factor

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Testa, G., Cacciatore, F., Galizia, G., Della-Morte, D., Mazzella, F., Russo, S., Ferrara, N., Rengo, F., Abete, P. (2009). Charlson Comorbidity Index does not predict long-term mortality in elderly subjects with chronic heart failure. Age Ageing 38: 734-740 [Abstract] [Full Text]  
• Riegel, B., Moser, D. K., Anker, S. D., Appel, L. J., Dunbar, S. B., Grady, K. L., Gurvitz, M. Z., Havranek, E. P., Lee, C. S., Lindenfeld, J., Peterson, P. N., Pressler, S. J., Schocken, D. D., Whellan, D. J., on behalf of the American Heart Association Counci, (2009). State of the Science: Promoting Self-Care in Persons With Heart Failure: A Scientific Statement From the American Heart Association. Circulation 120: 1141-1163 [Full Text]  
• Aukrust, P., Ueland, T., Gullestad, L., Yndestad, A. (2009). Testosterone: a novel therapeutic approach in chronic heart failure?. J Am Coll Cardiol 54: 928-929 [Full Text]  
• Kazory, A, Ross, E A (2009). Ultrafiltration for decompensated heart failure: renal implications. Heart 95: 1047-1051 [Abstract] [Full Text]